Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-073647
Filing Date
2010-03-31
Accepted
2010-03-31 17:19:30
Documents
11
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 876840
2 LICENSE AGREEMENT dex1033.htm EX-10.33 269603
3 EMPLOYMENT AGREEMENT dex1034.htm EX-10.34 23332
4 EMPLOYMENT AGREEMENT dex1035.htm EX-10.35 55838
5 AGREEMENT BETWEEN DR. JOHN YU AND IMMUNOCELLULAR dex1036.htm EX-10.36 28148
6 CONSENT OF STONEFIELD JOSEPHSON, INC dex231.htm EX-23.1 2409
7 CERTIFICATION OF THE REGISTRANT'S PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 10959
8 CERTIFICATION OF THE REGISTRANT'S PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 10945
9 CERTIFICATION OF THE REGISTRANT'S PRINCIPAL EXECUTIVE OFFICER dex321.htm EX-32.1 4160
10 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER dex322.htm EX-32.2 4120
11 GRAPHIC g44490g62l58.jpg GRAPHIC 16016
  Complete submission text file 0001193125-10-073647.txt   1310294
Mailing Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367 818-992-2907
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 033-17264-NY | Film No.: 10720456
SIC: 2834 Pharmaceutical Preparations